Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.48 |
| ▸ | ENPEP | Q07075 | 4/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.35 |
| ▸ | CASR | P41180 | 1/20 | 0.33 |
| ▸ | P2RY10 | O00398 | 2/20 | 0.31 |
| ▸ | GPR174 | Q9BXC1 | 2/20 | 0.31 |
| ▸ | ACE | P12821 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Threonine SCHEMBL4493263 | 0.93 | PTGS1 (0.42) | PTGS1SLC7A11ENPEPSLC7A5SLC1A3 | |
| SCHEMBL6389078 | 0.85 | PTGS1 (0.46) | PTGS1SLC7A11ENPEPSLC7A5SLC1A3 | |
| Cysteine SCHEMBL8071966 | 0.83 | ALOX15 (0.49) | PTGS1SLC7A11ENPEPSLC7A5SLC1A3 | |
| SCHEMBL1537267 | 0.83 | SLC7A5 (0.41) | PTGS1SLC7A11SLC7A5SLC1A3SLC1A2 | |
| SCHEMBL135879 | 0.83 | SLC7A5 (0.41) | PTGS1SLC7A11SLC7A5SLC1A3SLC1A2 | |
| SCHEMBL28554464 | 0.81 | SLC7A5 (0.40) | SLC7A5SLC1A3SLC1A2SLC1A1CASR | |
| SCHEMBL891923 | 0.81 | SLC7A5 (0.55) | SLC7A5SLC1A3SLC1A2SLC1A1CASR | |
| Tyrosine SCHEMBL3789571 | 0.81 | SLC7A5 (0.58) | PTGS1SLC7A5 | |
| SCHEMBL1964052 | 0.80 | SLC7A5 (0.39) | SLC7A5SLC1A3SLC1A2SLC1A1CASR | |
| Valine SCHEMBL4409191 | 0.79 | SLC7A5 (0.52) | SLC7A5SLC1A3SLC1A2SLC1A1CASR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100029005-A1 | Method of Quantifying Membrane Protein By Using Mass Spectrometer | TOHOKU UNIVERSITY (JP) | 2010-02-04 | — | — | US | claimed |
| EP-1953542-A1 | METHOD OF QUANTIFYING MEMBRANE PROTEIN BY USING MASS SPECTROMETER | TOHOKU UNIVERSITY (JP) | 2008-08-06 | — | — | EP | claimed |
| WO-2024076136-A1 | FUSION PEPTIDE COMPLEX COMPRISING TRANSMEMBRANE DOMAIN AND USE THEREOF | 주식회사 안단테에프엠 | 2024-04-11 | — | — | WO | disclosed |
| WO-2024049232-A1 | ANTIBACTERIAL PEPTIDE CONSISTING OF TRANSMEMBRANE PEPTIDE DOMAIN AND BASIC OR POLAR AMINO ACIDS AT OPPOSITE ENDS THEREOF AND VARIANTS THEREOF | 주식회사 안단테에프엠 | 2024-03-07 | — | — | WO | disclosed |
| EP-1953542-B9 | METHOD OF QUANTIFYING MEMBRANE PROTEIN BY USING MASS SPECTROMETER | UNIV TOHOKU (JP) | 2013-11-13 | — | — | EP | disclosed |
| EP-1953542-B1 | METHOD OF QUANTIFYING MEMBRANE PROTEIN BY USING MASS SPECTROMETER | UNIV TOHOKU (JP) | 2013-04-10 | — | — | EP | disclosed |
| US-7901942-B2 | Method of quantifying membrane protein by mass spectrometry using peptide selection criteria | TOHOKU UNIVERSITY (JP) | 2011-03-08 | — | — | US | disclosed |
| US-7829321-B2 | Method for the production of bacterial toxins | BAXTER INTERNATIONAL INC. (US) | 2010-11-09 | — | — | US | disclosed |
| US-7790185-B2 | Method for the production of bacterial toxins | BAXTER INTERNATIONAL INC. (US) | 2010-09-07 | — | — | US | disclosed |
| US-20100029005-A1 | Method of Quantifying Membrane Protein By Using Mass Spectrometer | TOHOKU UNIVERSITY (JP) | 2010-02-04 | — | — | US | disclosed |
| EP-1953542-A1 | METHOD OF QUANTIFYING MEMBRANE PROTEIN BY USING MASS SPECTROMETER | TOHOKU UNIVERSITY (JP) | 2008-08-06 | — | — | EP | disclosed |
| US-20050100553-A1 | Method for the production of bacterial toxins | BAXTER HEALTHCARE S.A. (CH) | 2005-05-12 | — | — | US | disclosed |
| US-6686180-B2 | GENERATING MICROORGANISMAL GENE EXPRESSION INHIBITORS; OBTAIN MICROORGANISM, CULTURE, EXPRESS MODULATORS OF GENE ACTIVITY IN CULTURE, RECOVER GENE EXPRESSION INHIBITORS | BAXTER INTERNATIONAL INC. | 2004-02-03 | — | — | US | disclosed |
| EP-1268531-A2 | METHOD FOR THE PRODUCTION OF BACTERIAL TOXINS | BAXTER INTERNATIONAL INC. (US) | 2003-01-02 | — | — | EP | disclosed |
| US-20020165344-A1 | Method for the production of bacterial toxins | BAXTER HEALTHCARE S.A. (CH) | 2002-11-07 | — | — | US | disclosed |
| US-20020061555-A1 | Method for the production of bacterial toxins | BAXTER HEALTHCARE S.A. (CH) | 2002-05-23 | — | — | US | disclosed |
| WO-2001074862-A2 | METHOD FOR THE PRODUCTION OF BACTERIAL TOXINS | BAXTER INTERNATIONAL INC. (US) | 2001-10-11 | — | — | WO | disclosed |
| WO-1994012205-A1 | DYNORPHIN A SUPPRESSION OF NATURAL KILLER CELL ACTIVITY | THE ROCKEFELLER UNIVERSITY (US) | 1994-06-09 | — | — | WO | disclosed |
| EP-0056249-B1 | SYNTHETIC ANTIGENIC COMPOSITION AND PROCESS FOR MAKING SAME | New York Blood Center, Inc. (US) | 1985-06-26 | — | — | EP | disclosed |
| EP-0056249-A2 | Synthetic antigenic composition and process for making same | New York Blood Center, Inc. (US) | 1982-07-21 | — | — | EP | disclosed |